Connection

Allen Kaplan to Molecular Weight

This is a "connection" page, showing publications Allen Kaplan has written about Molecular Weight.
Connection Strength

0.560
  1. Activation of the kinin-forming cascade on the surface of endothelial cells. Biol Chem. 2001 Jan; 382(1):71-5.
    View in: PubMed
    Score: 0.043
  2. Platelet glycoprotein Ib: a zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen. Mol Med. 1999 Aug; 5(8):555-63.
    View in: PubMed
    Score: 0.039
  3. Binding of activation of kinin-forming proteins on vascular endothelial cells. Immunopharmacology. 1997 Jun; 36(2-3):201-7.
    View in: PubMed
    Score: 0.034
  4. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). Proc Natl Acad Sci U S A. 1996 Aug 06; 93(16):8552-7.
    View in: PubMed
    Score: 0.032
  5. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J Biol Chem. 1993 Jun 05; 268(16):11982-7.
    View in: PubMed
    Score: 0.026
  6. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains. Blood. 1993 Mar 01; 81(5):1306-11.
    View in: PubMed
    Score: 0.025
  7. Histamine releasing factors and cytokine-dependent activation of basophils and mast cells. Adv Immunol. 1991; 50:237-60.
    View in: PubMed
    Score: 0.022
  8. Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III. J Clin Invest. 1990 May; 85(5):1516-21.
    View in: PubMed
    Score: 0.021
  9. Release of elastase from purified human lung mast cells and basophils. Identification as a Hageman factor cleaving enzyme. Inflammation. 1989 Jun; 13(3):295-308.
    View in: PubMed
    Score: 0.019
  10. Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody. J Immunol Methods. 1989 Apr 21; 119(1):19-25.
    View in: PubMed
    Score: 0.019
  11. Purification and further characterization of human mononuclear cell histamine-releasing factor. J Clin Invest. 1989 Apr; 83(4):1204-10.
    View in: PubMed
    Score: 0.019
  12. Studies of the cleavage of human high molecular weight kininogen by purified plasma and tissue kallikreins, and upon contact activation of plasma. Adv Exp Med Biol. 1989; 247B:317-24.
    View in: PubMed
    Score: 0.019
  13. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma. Blood. 1988 May; 71(5):1334-40.
    View in: PubMed
    Score: 0.018
  14. Study of the effect of high molecular weight kininogen upon the fluid-phase inactivation of kallikrein by C1 inhibitor. J Biol Chem. 1986 Nov 15; 261(32):14965-8.
    View in: PubMed
    Score: 0.016
  15. Assessment of histamine release and kinin formation in man: identification of kinin degradation products and characterization of a lymphocyte-dependent histamine releasing factor. Int Arch Allergy Appl Immunol. 1985; 77(1-2):64-8.
    View in: PubMed
    Score: 0.014
  16. Mechanisms of bradykinin generation in human plasma. Monogr Allergy. 1983; 18:272-6.
    View in: PubMed
    Score: 0.012
  17. Initiation of contact activation of human plasma. Adv Exp Med Biol. 1983; 156:45-61.
    View in: PubMed
    Score: 0.012
  18. The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein. J Biol Chem. 1982 Feb 25; 257(4):1779-84.
    View in: PubMed
    Score: 0.012
  19. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor. Thromb Res. 1980 Oct 15; 20(2):173-89.
    View in: PubMed
    Score: 0.011
  20. Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. J Biol Chem. 1980 Aug 10; 255(15):7281-6.
    View in: PubMed
    Score: 0.011
  21. Autoactivatability of human Hageman factor (factor XII). Biochem Biophys Res Commun. 1980 Feb 12; 92(3):803-10.
    View in: PubMed
    Score: 0.010
  22. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain. Proc Natl Acad Sci U S A. 1979 Oct; 76(10):4862-6.
    View in: PubMed
    Score: 0.010
  23. The role of high molecular weight kininogen in contact activation of coagulation, fibrinolysis and kinin generation. Adv Exp Med Biol. 1979; 120B:71-91.
    View in: PubMed
    Score: 0.009
  24. Structure-function correlation of human kininogen. Monogr Allergy. 1979; 14:212-7.
    View in: PubMed
    Score: 0.009
  25. Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen. J Exp Med. 1978 Feb 01; 147(2):488-99.
    View in: PubMed
    Score: 0.009
  26. Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest. 1977 Dec; 60(6):1376-80.
    View in: PubMed
    Score: 0.009
  27. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis. J Biol Chem. 1977 Sep 10; 252(17):6097-104.
    View in: PubMed
    Score: 0.009
  28. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest. 1977 Jul; 60(1):18-31.
    View in: PubMed
    Score: 0.008
  29. The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis. Monogr Allergy. 1977; 12:120-30.
    View in: PubMed
    Score: 0.008
  30. Mediator release from basophil granulocytes in chronic myelogenous leukemia. J Allergy Clin Immunol. 1976 Dec; 58(6):623-34.
    View in: PubMed
    Score: 0.008
  31. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci U S A. 1976 Nov; 73(11):4179-83.
    View in: PubMed
    Score: 0.008
  32. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation. Semin Thromb Hemost. 1976 Jul; 3(1):1-26.
    View in: PubMed
    Score: 0.008
  33. Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin. J Exp Med. 1974 Dec 01; 140(6):1615-30.
    View in: PubMed
    Score: 0.007
  34. Activation of factor XI in plasma is dependent on factor XII. Blood. 1993 Feb 01; 81(3):580-6.
    View in: PubMed
    Score: 0.006
  35. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator. J Exp Med. 1972 Dec 01; 136(6):1378-93.
    View in: PubMed
    Score: 0.006
  36. The IgE-dependent release of a Hageman factor cleaving factor from human lung. Am J Pathol. 1986 Apr; 123(1):146-54.
    View in: PubMed
    Score: 0.004
  37. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen. J Clin Invest. 1977 Jul; 60(1):7-17.
    View in: PubMed
    Score: 0.002
  38. Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor. Adv Exp Med Biol. 1976; 70(00):285-99.
    View in: PubMed
    Score: 0.002
  39. The use of isoelectric focusing to study components of the human plasma kinin-forming system. Ann N Y Acad Sci. 1973 Jun 15; 209:372-86.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.